Recurrent thyroid cancer: a molecular-based therapeutic breakthrough.

Lalami, Yassine; Awada, Ahmad

doi:doi/10.1097/CCO.0b013e3283448206

Recherche avancée | Historique de recherche Mon DI-fusion | À propos de DI-fusion | Contact |

Citer

Recurrent thyroid cancer: a molecular-based therapeutic breakthrough.

par Lalami, Yassine

;Awada, Ahmad

Référence Current opinion in oncology, 23, 3, page (235-240)
Publication Publié, 2011-05

Article révisé par les pairs

Résumé :

Thyroid cancer is a group of heterogeneous rare malignancies, with an increasing incidence. Management of recurrent thyroid cancer not amenable to local therapy such as surgery, radiotherapy or radio-iodine ablation remains very challenging. Indeed, chemotherapy allows a very limited impact on the outcomes of this cancer.

Documents en relation

DI-fusion

Retraction: Retracted] Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: A rationale to combine targeted drugs based on protein expression inhibition profiles (International journal of oncology (2013) 43 3 PII: 1 DOI: 10.3892/ijo.2013.2008)
par Aftimos, Philippe , Wiedig, Murielle , Langouo Fontsa, Mireille , Awada, Ahmad , Ghanem, Ghanem Elias , Journé, Fabrice
Publication 2025-01
A case report: Metastatic Gestational Trophoblastic Neoplasia leading to acute respiratory failure and death.About a particularly challenging management in the intensive care unit, and exploring the potential of Pembrolizumab in treating frail pretreated Gestational Trophoblastic Neoplasia
par Meyers, Michel , Awada, Ahmad , Najmaoui, Marine , Ilzkovitz, Maxime , Pezzullo, Martina , Chaves, Julia , Devière, Jacques , Halenarova, Katarina , Georgala, Aspasia , Fastrez, Maxime , Goffin, Frédéric M.S. , Polastro, Laura
Publication 2025-02
37P Lymphocyte subpopulation balances as a blood biomarker for immune-related adverse events in patients receiving immune checkpoint inhibitors
par Langouo Fontsa, Mireille , Stabile, Mario , Garavello, ACM , Delvaux, P. , Goudsmit, Anouk , Berghmans, Thierry , Da Rocha Almeida Brandao, Mariana , Blanc, Jeremy , Ilzkovitz, Maxime , Meert, Anne-Pascale , Boisson, Anaïs , Sofronii, Doina , Vanhulst, Thila , Garaud, Soizic , Padonou, Francine , Awada, Ahmad , Willard-Gallo, Karen
Publication 2024-12-01
Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint?
par Meyers, Michel , Mouna, Oumnia , Langouo Fontsa, Mireille
Publication 2025-03-01
Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy.
par Mouna, Oumnia , Hanssens, Charlotte , Meyers, Michel , Langouo Fontsa, Mireille
Publication 2025-03

Référencement	Visibilité	Pérennité	Facilité
Les publications encodées constituent la bibliographie académique de l'Université.	Les documents déposés sont indexés par les moteurs de recherche (Google Scholar,…).	Les documents déposés en open-access sont archivés au sein du réseau de préservation SAFE-PLN (www.safepln.org).	Les listes de publications sont compatibles avec le CV-ULB, le FNRS et accessibles sur le web.